title: Effects of a beta-blocker and spironolactone on plasma homocysteine levels.
authors.forename: Mehmet E
authors.initials: ME
authors.lastname: Korkmaz
authors.forename: Ilyas
authors.initials: I
authors.lastname: Atar
authors.forename: Egemen
authors.initials: E
authors.lastname: Tayfun
authors.forename: Aylin
authors.initials: A
authors.lastname: Yildirir
authors.forename: Melek
authors.initials: M
authors.lastname: Ulucam
authors.forename: Bülent
authors.initials: B
authors.lastname: Ozin
authors.forename: Haldun
authors.initials: H
authors.lastname: Muderrisoglu
authors.forename: Munire
authors.initials: M
authors.lastname: Turan
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000097:blood* / Q000517:prevention & control*; D006710:Homocysteine / Q000097:blood* / Q000187:drug effects*; D006801:Humans; D008790:Metoprolol / Q000494:pharmacology* / Q000627:therapeutic use*; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D013148:Spironolactone / Q000494:pharmacology* / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D000451:Mineralocorticoid Receptor Antagonists; D006710:Homocysteine; D013148:Spironolactone; D008790:Metoprolol